CellTivity Scientific, Inc.
PrivateLast Round
Early Funding
Apr 23, 2025
Total Funding Raised
$28.47M
Company Overview
CellTivity Scientific, Inc. is a biotechnology company that develops real-time, intraprocedural metabolic cellular imaging systems for cancer diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellTivity Scientific, Inc. Comparables
Compare CellTivity Scientific, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Instapath Inc. | 79% | |
| SamanTree Medical | 78% | |
| Optiscan Imaging Ltd | 78% |
CellTivity Scientific, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 23, 2025 | ||||
| Series A | Oct 6, 2023 | ||||
| Series A Extension | May 11, 2022 | ||||
| Series A Extension | Nov 15, 2021 |
Key People
Founding team and executive leadership
CellTivity Scientific, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Capital | Series A Extension |
| SternAegis Ventures | Series A Extension |
| Aegis Capital Corp. | Series A |
| Ceros Capital Markets | Series A Extension |
| Weild Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2025
Grew 21% QoQ from 19 to 23 employees.
- Mar 14, 2025
Grew 17% QoQ, from 18 to 21 employees.
CellTivity Scientific, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CellTivity Scientific, Inc.'s valuation, stock price, and market status.
Is AQUYRE Biosciences a public or private company?
AQUYRE Biosciences is a private company.
What is the current stock price of AQUYRE Biosciences?
AQUYRE Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is AQUYRE Biosciences worth (valuation)?
Valuation information for AQUYRE Biosciences is not publicly available.
Can I buy AQUYRE Biosciences stock?
AQUYRE Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AQUYRE Biosciences's last funding round?
AQUYRE Biosciences's most recent funding round was Series A on October 20, 2023.
Who are the main investors in AQUYRE Biosciences?
Key investors in AQUYRE Biosciences include HealthTech Capital, SternAegis Ventures, Aegis Capital Corp., Ceros Capital Markets, Weild Capital.
Will AQUYRE Biosciences IPO soon?
No public IPO plans have been announced for AQUYRE Biosciences.
How can I track AQUYRE Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AQUYRE Biosciences's secondary market activity and sign up for updates.